Opportunity
Merx #SN26002
Subscription to Drug Pricing Intelligence Database for PMPRB
Posted
April 10, 2026
Respond By
April 27, 2026
Identifier
SN26002
NAICS
518210
The Patented Medicine Prices Review Board (PMPRB), a Canadian federal agency, is seeking a subscription to a comprehensive drug pricing intelligence database to support its mandate for international pharmaceutical price analysis. - Government Buyer: - Patented Medicine Prices Review Board (PMPRB), Canada - Products/Services Requested: - Subscription to an integrated platform providing: - Comprehensive, structured, and regularly updated international pricing and reimbursement information - Analytics and intelligence for pharmaceuticals - Supporting services for data analysis - No specific part numbers or quantities provided - OEMs and Vendors: - No specific OEMs or vendors are named in the notice - Unique or Notable Requirements: - Service must deliver international drug pricing intelligence and analytics - Platform must be regularly updated and comprehensive - Requirement is for a service subscription, not a physical product
Description
The Patented Medicine Prices Review Board (PMPRB) in Canada is seeking a subscription to an integrated platform that provides comprehensive, structured, and regularly updated international pricing and reimbursement information, analytics, and intelligence for pharmaceuticals. This service supports PMPRB's work in gathering and analyzing global pricing and reimbursement regimes and trends. The procurement is an Advance Contract Award Notice (ACAN) with a publication date of April 10, 2026, and a closing date of April 27, 2026. The contact person for this solicitation is Sylvie Beaudoin.